MAPT and breast carcinoma: In Figure 3B, we can see 7 lncRNAs are favorable prognostic factors (USP30-AS1, ST7-AS1, VPS9D1-AS1, TFAP2A-AS1, HOXB-AS1, LINC01087, and MAPT-AS1) and 2 lncRNAs are unfavorable prognostic factors (KMT2E-AS1, OTUB6DB-AS1) for breast cancer patients.